Table 2.
Tel Aviv | Philadelphia | |||||||
---|---|---|---|---|---|---|---|---|
| ||||||||
22q11.2DS (n = 52) | WS (n =21) | TD (n = 32) | Statistics (df=2, 102) | 22q11.2DS (n = 119) | IDD (n = 129) | TD (n = 800) | Statistics (df=2, 1047) | |
Age in years | 20.97 (6.49) | 21.50 (6.12) | 20.05 (6.52) | F=0.361 p=0.70 |
16.51 (2.71) | 15.83 (2.43) | 16.29 (2.70) | F=2.276 P=0.10 |
Age Range | 12.00–36.00 | 11.10 – 36.01 | 11.00 – 34.00 | 12.08 – 22.0 | 12.00 – 21.42 | 12.00– 21.83 | ||
Sex (n, % male) | 26 (50.0) | 8 (38.0) | 12 (47.0) | χ2=0.85 P= 0.65 |
75 (63.0) | 78 (60.5) | 483 (60.4) | χ2=0.31 p=0.86 |
Full scale IQ | 77.98 (11.4) | 65.95 (11.3) | 103.23 (7.6) | F=91.01 p<0.001 |
77.04 (12.83) | NA | NA | |
IQ Range | 58–100 | 40–88 | 88–120 | 47 – 106 | NA | NA | ||
Average parental education in years | 13.43 (2.3) | 14.05 (2.05) | 14.72 (2.2) | χ2=1.37 p=0.51 |
14.57 (2.04) | 14.11 (2.12) | 14.81 (2.36) | IDD > TD χ2=8.31 P = 0.16 |
Ethnicity (n, %) | ||||||||
Caucasian | 52 (100.0) | 21 (100.0) | 32 (100.0) | 103 (85.1) | 80 (63.0) | 528 (66.8) | ||
African American | 0 (0.0) | 0 (0.0) | 0 (0.0) | 12 (9.9) | 34 (26.8) | 195 (24.7) | ||
Other | 0 (0.0) | 0 (0.0) | 0 (0.0) | 6 (5.0) | 13 (10.2) | 67 (8.5) | ||
Medication (current)* | ||||||||
Antipsychotics | 1 (1.9) | 0 (0.0) | 0 (0.0) | 2 (1.7) | 7 (5.4) | 2 (0.25) | ||
Mood stabilizers | 0 (0.0) | 1 (4.8) | 0 (0.0) | 5 (4.2) | 16 (12.4) | 1 (0.13) | ||
Anti- depressants | 11 (21.2) | 2 (9.5) | 0 (0.0) | 12 (10.1) | 18 (14.0) | 12 (1.5) | ||
Stimulants | 9 (17.3) | 2 (9.5) | 0 (0.0) | 7 (5.9) | 19 (14.7) | 18 (2.3) | ||
Anxiolytics | 0 (0.0) | 0 (0.0) | 0 (0.0) | 2 (1.7) | 1 (0.8) | 1 (0.13) |
Mean (SD);
Several participants are on multiple medications.